Insulin Resistance: Pathophysiology and Rationale for Treatment

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Nutrition and Metabolism

• Publication date

  2011-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000323395PMID 21304221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

  2009cited by this paper
• A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation.

  2009cited by this paper
• Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

  2009cited by this paper
• Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy

  2009cited by this paper
• Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

  2009cited by this paper
• The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality

  2009cited by this paper
• Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

  2009cited by this paper
• Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

  2009cited by this paper
• Mitochondrial fitness and insulin sensitivity in humans

  2008cited by this paper
• Fatty Acid Oxidation and Insulin Action

  2008cited by this paper
• Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study.

  2008cited by this paper
• Ceramide: a contributor to insulin resistance or an innocent bystander?

  2008cited by this paper
• Ectopic fat and insulin resistance

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Carnitina e diabete

  2008cited by this paper
• Effects of chronic hyperinsulinemia in insulin-resistant patients

  2008cited by this paper
• The role of the lipogenic pathway in the development of hepatic steatosis.

  2008cited by this paper
• Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus

  2008cited by this paper
• Implementing the national priorities for injury surveillance

  2008cited by this paper
• Insulin Resistance Concepts

  2007cited by this paper
• Insulin treatment in the absence of dependence

  2007cited by this paper
• Demonstration of the mechanism of action of biguanides

  2007cited by this paper
• The role of glitazones in management of type 2 diabetes. A DREAM or a nightmare?

  2007cited by this paper
• Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery

  2007cited by this paper
• Diabetes drug pioglitazone (Actos): risk of fracture

  2007cited by this paper
• Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus

  2007cited by this paper
• Carnitine revisited: potential use as adjunctive treatment in diabetes

  2007cited by this paper
• Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery.

  2007cited by this paper
• Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System

  2007cited by this paper
• Lipids in Health and Disease

  2007cited by this paper
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial

  2007cited by this paper
• The rosiglitazone story--lessons from an FDA Advisory Committee meeting.

  2007cited by this paper
• Metformin and heart failure: innocent until proven guilty.

  2006cited by this paper
• Exogenous insulin use and hypertension in adult patients with type 2 diabetes mellitus.

  2006cited by this paper
• Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.

  2006cited by this paper
• Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

  2006cited by this paper
• Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

  2006cited by this paper
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

  2006cited by this paper
• Is insulin resistance atherogenic? Possible mechanisms.

  2006cited by this paper
• Diabetes and the metabolic syndrome--when is it best to intervene to prevent?

  2006cited by this paper
• Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.

  2006cited by this paper
• Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin

  2006cited by this paper
• Metformin and Heart Failure: Innocent Until Proven Guilty

  2006cited by this paper
• The metabolic syndrome: is this diagnosis necessary?

  2006cited by this paper
• Pathogenesis of nonalcoholic steatohepatitis (NASH).

  2006cited by this paper
• Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction

  2006cited by this paper
• Insulin Causes [Ca2+]i-Dependent and [Ca2+]i-Independent Positive Inotropic Effects in Failing Human Myocardium

  2005cited by this paper
• Inflammation, stress, and diabetes.

  2005cited by this paper
• Metformin and heart failure: innocent until proven guilty.

  2005cited by this paper
• Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study.

  2005cited by this paper
• The Role of Insulin Resistance and Hyperinsulinemia in Cancer Causation

  2005cited by this paper
• Insulin Causes [Ca ]i-Dependent and [Ca ]i-Independent Positive Inotropic Effects in Failing Human Myocardium

  2005cited by this paper
• Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study

  2005cited by this paper
• Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.

  2005cited by this paper
• Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes

  2005cited by this paper
• Insulin treatment and cardiovascular disease; friend or foe? A point of view

  2005cited by this paper
• FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke

  2005cited by this paper
• Type 2 diabetes mellitus, its treatment and risk for lymphoma.

  2005cited by this paper
• Diabetes, insulin therapy, and colorectal cancer

  2005cited by this paper
• Carnitine in Type 2 Diabetes

  2004cited by this paper
• A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study.

  2004cited by this paper
• The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults

  2004cited by this paper
• L-carnitine.

  2004cited by this paper
• The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort.

  2004cited by this paper
• Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor

  2004cited by this paper
• Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach.

  2004cited by this paper
• Metabolic therapy for heart failure.

  2004cited by this paper
• Pathogenesis of type 2 diabetes mellitus.

  2004cited by this paper
• Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase

  2004cited by this paper
• The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort.

  2004cited by this paper
• Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.

  2004influential reference
• Molecular mechanisms of insulin resistance that impact cardiovascular biology.

  2004cited by this paper
• Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.

  2003cited by this paper
• From presumed benefit to potential harm--hormone therapy and heart disease.

  2003cited by this paper
• Polycystic Ovary Syndrome and the Metabolic Syndrome

  2003cited by this paper
• Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women

  2003cited by this paper
• Book Review Skeletal Muscle: Pathology, Diagnosis, and Management of Disease Edited by Victor Preedy and Timothy Peters. 716 pp., illustrated. London, Greenwich Medical Media, 2002. $199. 1-84110-029-3

  2003cited by this paper
• Fatty acid metabolism in obesity and type 2 diabetes mellitus

  2003cited by this paper
• Diabetic dyslipidaemia: from basic research to clinical practice*

  2003cited by this paper
• Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.

  2003cited by this paper
• Does low meat consumption increase life expectancy in humans?

  2003cited by this paper
• The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

  2002cited by this paper
• Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.

  2002cited by this paper
• The extracellular matrix on atherogenesis and diabetes-associated vascular disease.

  2002cited by this paper
• Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells*

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333

  2002cited by this paper
• Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

  2002cited by this paper
• Evaluation of the Carcinogenic Potential of Insulin Glargine (LANTUS) in Rats and Mice

  2002cited by this paper
• Lipotoxicity in human pancreatic islets and the protective effect of metformin.

  2002cited by this paper
• The obesity epidemic: pathophysiology and consequences of obesity.

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Insulin Glargine: A New Basal Insulin

  2002cited by this paper
• The evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes

  2002cited by this paper
• Dysregulation of Fatty Acid Metabolism in the Etiology of Type 2 Diabetes

  2001cited by this paper
• Liver fibrosis and NA(+)/H(+) exchange.

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Diet and risk of Type II diabetes: the role of types of fat and carbohydrate

  2001cited by this paper

• Anthropometric predictors of insulin resistance in Iraqi healthy adults

  2025cites this paper
• Biochemical, sex hormonal, and anthropometric predictors of non-alcoholic fatty liver disease in polycystic ovary syndrome

  2025cites this paper
• Differential expression of microRNA in the serum of patients with polycystic ovary syndrome with insulin resistance

  2022cites this paper
• Polycystic ovary syndrome and obesity: a modern paradigm

  2022cites this paper
• Why are women with polycystic ovary syndrome obese?

  2022cites this paper
• Obesity and polycystic ovary syndrome

  2021cites this paper
• Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction

  2021cites this paper
• ChaiQi Decoction Alleviates Vascular Endothelial Injury by Downregulating the Inflammatory Response in ApoE-Model Mice

  2021cites this paper
• Mitochondrial dysfunction in metabolic disorders

  2021cites this paper
• Summery and perspective for future research on insulin resistance and insulin resistance–linked visceral and neurological disorders

  2020cites this paper
• The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer

  2020cites this paper
• The role of selenium in insulin resistance

  2018cites this paper
• Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells

  2018cites this paper
• Moderating Effect of Insulin Resistance on the Relationship between Gray Matter Volumes and Cognitive Function

  2018cites this paper
• Atherosclerosis is a vascular stem cell disease caused by insulin.

  2018cites this paper
• Impact of Optimized Protein in Infant Formula on the Metabolic and Nutritional Health in Infants: Systematic Review with Meta-Analysis

  2017cites this paper
• Manifestaciones cutáneas como diagnóstico precoz de enfermedades endocrinas en pacientes pediátricos

  2017cites this paper
• PENGARUH PEMBERIAN TRANS FATTY ACID

  2017cites this paper
• Inflammatory Networks Linking Cardiovascular Disease, Diabetes, and Cancer

  2017cites this paper
• Prevalence of glucometabolic disorders in acute coronary syndrome and their prognostic influence in long term cardiovascular outcome

  2016cites this paper
• The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema

  2016cites this paper
• Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy’s safety profile

  2016cites this paper
• Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.

  2016cites this paper
• Is type 2 diabetes mellitus a predisposal cause for developing hepatocellular carcinoma?

  2015cites this paper
• Insulin resistance in pregnancy complicated by type 1 diabetes mellitus. Do we know enough?

  2015cites this paper
• Atherogenesis, coronary heart disease and insulin resistance syndrome in diabetes

  2015cites this paper
• Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

  2015cites this paper
• The therapy of insulin resistance in other diseases besides type 2 diabetes

  2014cites this paper
• Regulation of Early Human Growth: Impact on Long-Term Health

  2014cites this paper
• Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and Back

  2013cites this paper
• Early influences of nutrition on postnatal growth.

  2013cites this paper
• U-500 concentrated regular insulin: Practical application in the outpatient setting

  2012influential citation
• Insulin resistance in the nervous system.

  2012cites this paper
• Diabetes and Peripheral Vascular Disease

  2012cites this paper
• The Pathogenesis of Diabetic Atherosclerosis

  2012cites this paper
• Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Diabetes und metabolischen Störungen

  2011cites this paper
• The combination pharmaceutical composition and method for treatment of diabetes and metabolic disorders

  2011cites this paper
• Basal glucose metabolism and peripheral insulin sensitivity in equine pituitary pars intermedia dysfunction

  2011cites this paper